`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Mylan Pharmaceuticals Inc., Petitioner
`
`v.
`
`Nissan Chemical Indushies Ltd.
`Patent Owner
`
`U.S. Patent No. 5,856,336 to Fujikawa et al.
`Issue Date: January 5, 1999
`Title: Quinoline Type Mevalonolactones
`
`Inter Partes Review No.: IPR2015 -01069
`
`PETITIONER'S POWER OF ATTORNEY PURSUANT TO 37 C.F.R.
`§ 42.10(b) FOR INTER PARTES REVIEW OF
`U.S. PATENT NO. 5,856,336
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313 -1450
`
`Alston & Bird LIT
`
`NCI Exhibit 2037
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Mylan Pharmaceuticals Inc.,
`
`( "Petitioner ") hereby appoints the practitioners associated with Alston &
`
`Bird LLP Customer Number 00826, including the following lead and backup
`
`counsel, as its attorneys to transact all business in the United States Patent &
`
`Trademark Office associated with the above -captioned Petition for Inter
`
`Partes Review of U.S. Patent No. 5,856,336 on behalf of Petitioner:
`
`Lead Counsel
`Jitendra Malik
`Reg. No. 55823
`ALSTON & BIRD LLP
`4721 Emperor Blvd., Suite 400
`Durham, North Carolina 27703
`
`Back -Up Counsel
`Deanne M. Mazzochi
`Reg. No. 50158
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard St., Suite 500
`Chicago, Illinois 60654
`
`Alston & Bird LLP
`
`2
`
`
`
`By:
`
`y
`
`Name: cr Km/ Y. Ft Ma
`
`Title: YAL.7.4.UtS,7
`
`élLtigfiL Zet "1.14
`
`Date:
`
`ittp,,His.
`
`/7. :ors
`
`Mylan Pharmaceuticals Inc.
`
`Alston & Bird LLP
`
`3